share_log

新天药业:董事会关于本次交易预计构成《上市公司重大资产重组管理办法》第十二条规定的重大资产重组但不构成重组上市的说明

Xintian Pharmaceutical: Explanation of the Board of Directors that this transaction is expected to constitute a major asset restructuring as stipulated in Article 12 of the “Administrative Measures on Major Asset Reorganization of Listed Companies”, but no

深证信a股 ·  Mar 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more